e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Pulmonary circulation: clinical end-points and clinical physiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The proANP increase during exercise may predict the PAP increase in connective tissue disease patients at risk of PAH
M. Tscherner, G. Kovacs, F. Fruhwald, R. Maier, B. Obermayer-Pietsch, A. Avian, V. Foris, H. Olschewski (Graz, Austria)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Session:
Pulmonary circulation: clinical end-points and clinical physiology
Session type:
Thematic Poster Session
Number:
3923
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tscherner, G. Kovacs, F. Fruhwald, R. Maier, B. Obermayer-Pietsch, A. Avian, V. Foris, H. Olschewski (Graz, Austria). The proANP increase during exercise may predict the PAP increase in connective tissue disease patients at risk of PAH. Eur Respir J 2012; 40: Suppl. 56, 3923
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Does lung function predict response to therapy in PAH associated with connective tissue disease?
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension
Source: Eur Respir J, 51 (6) 1800467; 10.1183/13993003.00467-2018
Year: 2018
Increased risk of peripheral arterial disease in individuals with COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
Borderline pulmonary hypertension was associated with reduced cardiac output during exercise in patients withconnective tissue diseases
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
Elevated pulmonary vascular resistance is associated with increased risk of death in IPF
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019
Year: 2019
Elevated pulmonary vascular resistance predicts mortality in COPD patients
Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Year: 2021
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
Distance assessment of the risk of pulmonary hypertension associated with connective tissue diseases: do biomarkers help?
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
The role of cardiopulmonary exercise testing in assessment of the severity of patients with PAH associated with congenital heart disease.
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
NT-pro-BNP levels are independent of exercise in pulmonary hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Early risk prediction in idiopathic
versus
connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Year: 2021
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Ambrisentan therapy for patients with PAH associated with connective tissue disease (PAH-CTD): one year follow-up
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Sitaxsentan improves 6MW and hemodynamics in patients with pulmonary arterial hypertension (PAH) related to connective tissue disease (CTD)
Source: Eur Respir J 2005; 26: Suppl. 49, 564s
Year: 2005
Epicardial fat mass is increased in patients with COPD: A non-invasive cardiovascular marker in a high risk population
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept